Sandra E. Dunn - Concepedia

Author

Sandra E. Dunn

Also Known As

Dr. Sandra Dunn, Dunn, Sandra E., M. Issaivanan, S E Dunn, S. Dunn, S. E. Dunn, S. Pomeroy, S.E. Dunn, Sandra Dunn, Sandra E Dunn

215

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia Child and Family Research Institute BC Cancer Agency BC Children's Hospital Vancouver General Hospital

About

Sandra E. Dunn is an author at University of British Columbia specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	33	4K
2	Health Sciences	5	5	563
3	Biochemistry	3	3	86
4	Engineering	1	1	643
5	Social Sciences	1	1	89

Sandra E. Dunn

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations Pawel Buczkowicz, Christine M. Hoeman, Patricia Rakopoulos, Nature Genetics Neuro-oncologyRadiation OncologyEngineeringTumor HeterogeneityMedicine	2014	643
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Sandra E. Dunn, Frank W. Kari, John E. French, PubMed NutritionChemoprevention StrategyPathologyCell ProliferationCaloric Restriction	1997	440
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival Jennifer Law, Golareh Habibi, Kaiji Hu, Cancer Research	2008	404
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis Vijay Ramaswamy, Marc Remke, Éric Bouffet, The Lancet Oncology Neuro-oncologyTumoral PathologyOncologyTumor HeterogeneityRecurrence Patterns	2013	393
Divergent clonal selection dominates medulloblastoma at recurrence A. Sorana Morrissy, Livia Garzia, David Shih, Nature Neuro-oncologySomatic VariantTumor HeterogeneityMedicineGenetics	2016	339
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells Brent W. Sutherland, Jill E. Kucab, Joyce C. Wu, Oncogene Protein FunctionSignal TransductionSignaling PathwayCell RegulationBreast Cancer Cells	2005	298
A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Sandra E. Dunn, Melanie Ehrlich, N J Sharp, PubMed Tumor BiologyBreast OncologyMedicineImmunologyCancer Growth	1998	278
Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in Tumors Damien Faury, André Nantel, Sandra E. Dunn, Journal of Clinical Oncology	2007	216
Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma Nikita Makretsov, David G. Huntsman, Torsten O. Nielsen, Clinical Cancer Research	2004	203
Y-Box Binding Protein-1 Induces the Expression of <i>CD44</i> and <i>CD49f</i> Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance Karen To, Abbas Fotovati, Kristen M. Reipas, Cancer Research	2010	166

Page 1